Frailty and mortality, disability and mobility loss in a Spanish cohort of older adults: the FRADEA study.
Pedro Abizanda, Luis Romero, Pedro M Sánchez-Jurado...
https://pubmed.ncbi.nlm.nih.gov/23107816/Actively Recruiting
Led by Complejo Hospitalario Universitario de Albacete · Updated on 2025-03-18
273
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating an intervention based on the Spanish Healthcare Ministrys algorithm to reduce frailty status or improve physical function in community-dwelling older adults aged 70 and above. This multicenter randomized clinical trial includes prefrail or frail participants or those with a gait speed under 0.8 ms, aiming to assess the interventions effectiveness at the primary care level. Secondary goals include evaluating cost-effectiveness and impacts on hospitalizations, emergency visits, disability, falls, institutionalization, mortality, primary care visits, drug use, and quality of life. The study compares two groups one receiving a group multicomponent physical exercise program, nutritional intervention, and frailty training delivered by trained experts in groups of six, and a control group receiving usual care with healthy lifestyle advice. The exercise program includes balance, flexibility, strength, and power exercises, performed twice weekly for 45 minutes over two 12-week periods separated by a two-month break. Nutritional guidance is provided based on assessments, with referrals to geriatrics when needed. Participants undergo baseline assessments including Barthel index, frailty phenotype, and gait speed measurements, with follow-up visits at 3, 5, and 8 months to monitor changes. Data collection uses electronic tools ensuring secure and anonymized storage. The main outcome is the change in frailty status or physical function after 8 months, with secondary outcomes including hospitalizations, emergency visits, and mortality over one year. Adverse events are monitored throughout the trial, which is planned to conclude by March 2025.
CONDITIONS
RCT to Analyze the Efficacy of a Spanish Healthcare ministRy Based In InTervention to Reduce Frailty Status in Prefrail Older Adults
P
Pedro Abizanda Soler, MD,PhD
A
Almudena Avendaño Céspedes, RN, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Complejo Hospitalario Universitario de Albacete
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 8 months including exercise cycles and break periods
Participants in the intervention group engage in a group multicomponent physical exercise program twice a week for 12 weeks, repeated twice with a 2-month break between cycles. Nutritional recommendations are provided by a nutritionist and Primary Care Physicians may refer high-risk participants to a Geriatrics Department. Control group participants receive usual care and healthy lifestyle recommendations.
Twice weekly exercise sessions for 12 weeks, repeated twice with a 2-month break; nutritional consultations at the start of intervention
Duration - Up to 8 months
Participants have follow-up visits to analyze results and monitor adverse events at 3, 5, and 8 months after starting the intervention.
3 visits at 3, 5, and 8 months
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Pedro Abizanda, Luis Romero, Pedro M Sánchez-Jurado...
https://pubmed.ncbi.nlm.nih.gov/23107816/Adriana Abizanda Saro, Rafael García Molina, Rubén Alcantud Córcoles...
https://pubmed.ncbi.nlm.nih.gov/41456342/João Apóstolo, Richard Cooke, Elzbieta Bobrowicz-Campos...
https://pubmed.ncbi.nlm.nih.gov/29324562/Gotaro Kojima
https://pubmed.ncbi.nlm.nih.gov/26933121/Gotaro Kojima
https://pubmed.ncbi.nlm.nih.gov/27341327/Gotaro Kojima, Steve Iliffe, Kate Walters
https://pubmed.ncbi.nlm.nih.gov/29040347/Emiel O Hoogendijk, Luis Romero, Pedro M Sánchez-Jurado...
https://pubmed.ncbi.nlm.nih.gov/30853426/Francisco José Tarazona-Santabalbina, Mari Carmen Gómez-Cabrera, Pilar Pérez-Ros...
https://pubmed.ncbi.nlm.nih.gov/26947059/Complejo Hospitalario Universitario de Albacete
Lead Sponsor